Welcome!
Home Chinese market
Broker's Calls
PhillipCapital 'remains confident' in iX Biopharma’s growth prospects upon China agreement
PhillipCapital has kept its "buy" recommendation with the same target price of 44.5 cents.
April 08, 2021
Stocks To Watch
UOBKayHian names a focus on stability and selected cyclicals as good investment strategies for 4Q2020
Check out these counters, says UOB Kay Hian
October 20, 2020
China Focus
China's coupon-led recovery
Local Chinese governments have distributed about RMB4 billion ($807.6 million) of digital coupons in the past few days.
April 03, 2020
Commentary
Reassessment of investing strategies required as investment sands are shifting
SINGAPORE (Apr 15): Where do I allocate my long-term investment capital to maximise growth? Globalisation offered many opportunities and a means to diversify risk. It made sense to allocate funds to US markets and to the fast-rising Chinese markets. I, li
April 15, 2019